Abstract
ABSTRACT: Type I tyrosinemia (HTI) is an autosomally recessively inherited disease caused by deficiency of fumarylacetoacetate hydrolase. The disease manifests with liver failure, renal tubular defects, and neurologic crises. Currently orthotopic liver transplantation (OLT) enables patients to survive. However, renal fumarylacetoacetate hydrolase deficiency is not corrected by OLT, and the long-term prognosis of the nephropathy is not known. We investigated tyrosine metabolism, GFR, renal tubular function, and histopathology before and 18-36 mo after OLT in eight patients with HTI. Progressive renal dysfunction was not documented despite continuing, although diminished, urinary succinylacetone excretion in all patients. The mean GFR was 82 mL/min/1.73 m2 before and 102 mL at 18 mo and 93 mL at 36 mo after OLT. All patients showed tubular dysfunction before OLT. At 18 mo, glucosuria occurred in one, amino aciduria and phosphaturia in three, and hypercalciuria in six patients. Only hypercalciuria was seen at 36 mo. Renal biopsies showed mild nonspecific changes caused either by minimal progression of the renal disease or by mild cyclosporine nephrotoxicity. In conclusion, patients with HTI had normal GFR, but showed signs of tubular dysfunction 18–36 mo after OLT. Renal function and histopathology should be monitored after OLT for HTI.
Similar content being viewed by others
Article PDF
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Laine, J., Salo, M., Krogerus, L. et al. The Nephropathy of Type I Tyrosinemia after Liver Transplantation. Pediatr Res 37, 640–645 (1995). https://doi.org/10.1203/00006450-199505000-00015
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1203/00006450-199505000-00015
This article is cited by
-
Liver Transplantation: A Safe and Definitive Alternative to Lifelong Nitisinone for Tyrosinemia Type 1
Indian Journal of Pediatrics (2022)
-
Early nitisinone treatment reduces the need for liver transplantation in children with tyrosinaemia type 1 and improves post‐transplant renal function
Journal of Inherited Metabolic Disease (2014)
-
Plasma succinylacetone is persistently raised after liver transplantation in tyrosinaemia type 1
Journal of Inherited Metabolic Disease (2013)
-
Renal function in tyrosinaemia type I after liver transplantation: A long‐term follow‐up
Journal of Inherited Metabolic Disease (2005)
-
Tyrosinemia: A Review
Pediatric and Developmental Pathology (2001)